ICIQ Advisory Board

The ICIQ Advisory Board is made up of clinicians, experts in questionnaire design and representatives from the pharmaceutical industries. Collaboration of these individuals is essential to ensuring the acceptability of questionnaires and to ensure production of high quality questionnaires that will meet users’ needs.

Below is a list of the Advisory Board :

Lucy Abraham, Research Fellow, Pfizer
Professor Paul Abrams, Professor of Urology and Chair ICI
Dr. Kerry Avery, Research Associate
Dr Anthony Beardsworth
Dr. John Bolodeoku, Astellas Pharma Europe
Professor Ruud Bosch, Professor of Urology and Vice Chair of Symptom and Quality of Life Assessment Committee
Dr. Richard Bump, Medical Advisor, Eli Lilly and Company Ltd. and Associate Editor American Journal of Obstetrics and Gynecology
Professor Linda Cardozo, Professor of Urogynaecology and Vice Chair ICI
Professor Jenny Donovan, Professor in Social Medicine and Chair of Symptom and Quality of Life Assessment Committee
Mr Marcus Drake, Consultant Urological Surgeon
Nikki Gardener, Research Nurse/Associate
Dr. Mario de Gennaro, Paediatric Urologist
Tove Holm-Larsen, Clinical Research Associate, Ferring Pharmaceuticals
Dr. Jasper Huels, Head Health Economics and Pricing Strategy, Novartis Pharma AG
Dr. Iqbal Hussain, Urologist, Pfizer
Mr. Simon Jackson, Consultant Gynaecologist
Dr. Con Kelleher, Gynaecologist
Roy Khoury, Global Communications Manager Enablex, Novartis Pharma AG
Zoë Kopp, Senior Manager Outcomes Research, Pfizer
Dr. Charles Marotta, Director of Health Economics and Outcomes Research, AstraZeneca Pharmaceuticals
Dr. Jens Peter Nørgaard, Urologist, Chief Scientific Officer Clinical Research and Development (Urology) Ferring Pharmaceuticals
Professor Christine Norton, Professor in Gastrointestinal Nursing, Nurse Consultant and Chair of Conservative and Pharmacological Management of Faecal Incontinence in Adults Committee
Dr. Natalia Price, Registrar in Gynaecology
Dr. Stephen Radley, Consultant Gynaecologist
Dr. Carlo Rizzi, International Clinical Team Leader, Boehringer Ingelheim
LuAnn Sabounjian, Vice President, Clinical Research, Indevus Pharmaceuticals
David Sykes, Senior Health Outcomes Research Scientist, Eli Lilly and Company Ltd.
Professor Andrea Tubaro, Associate Professor of Urology

 

 

 

^ back to the top

site map | terms of use | privacy policy | contact us
© Bristol Urological Institute 2014
Use of this website signifies your agreement to the terms of use